Important COVID Vaccination Program Guidance (Oct. 25, 2021) The attached information was sent to all providers enrolled in the NYS COVID-19 vaccination program. It is updated to reflect the FDA authorization and CDC approval of Moderna and J&J booster doses for eligible individuals and the administration of heterologous booster doses. Included are: The attached Guidance for The […]
For Immediate Release October 1, 2021 Surprise Billing Legislation Interim Final Rule: MSSNY Calls for Prioritizing Patient Care Over Insurance Profits Statement Attributable to: Joseph R. Sellers, MD, FAAP, FACP President, Medical Society of the State of New York “While MSSNY is continuing to review the HHS interim final rule implementing aspects of the federal No […]
For Immediate Release New AMA Substance Use and Pain Care Task Force Urges Action to Help Patients September 29, Westbury, NY— The Medical Society of the State of New York and the American Medical Association today released new recommendations as part of the AMA Substance Use and Pain Care Task Force to help end the […]
For Immediate Release September 29, 2021 MSSNY Applauds Gov. Hochul’s Appointment of Mary Bassett, MD, MPH as NYS Department of Health Commissioner Statement Attributable to: Joseph R. Sellers, MD, FAAP, FACP President, Medical Society of the State of New York “MSSNY is thrilled to welcome Dr. Mary Bassett as New York State’s new Health […]
For Immediate Release September 28, 2021 AMA, MSSNY Strongly Support Governor Hochul’s Efforts to Require Health Care Workers to be Vaccinated Against COVID-19 Statement Attributable to: Joseph R. Sellers, MD, FAAP, FACP President, Medical Society of the State of New York Gerald E. Harmon, M.D. President, American Medical Association “The American Medical Association (AMA) […]
Dear COVID-19 Vaccination Provider: On September 24, 2021, under the U.S. Food and Drug Administration’s (FDA) updated emergency use authorization (EUA), the CDC issued recommendations for a single dose of the Pfizer-BioNTech COVID-19 Vaccine at least six months after completion of the primary series for the following individuals: individuals 65 years of age and older, and […]
Pfizer-BioNTech COVID-19 Vaccine Licensure and Expiration Extension Dear COVID-19 Vaccination Provider, The FDA granted full licensure for Pfizer’s COVID-19 vaccine on August 23, 2021. The full licensure applies to the use of this vaccine in the 16+ population. The vaccine also continues to be available under emergency use authorization (EUA) for adolescents 12 through 15 years of age and […]
Janssen/Johnson & Johnson COVID-19 Vaccine Expiration Extension On July 29, 2021, the U.S. Food & Drug Administration (FDA) authorized an extension of the shelf life for the Janssen/Johnson & Johnson (J&J) single-shot COVID-19 vaccine by 45 days, from 4.5 months to 6 months. The decision is based on data from ongoing stability assessment studies, which have […]
Important Information regarding Janssen/Johnson & Johnson (J&J) COVID-19 Vaccine On July 13, 2021, the U.S. Food and Drug Administration (FDA) announced revisions to the Emergency Use Authorization (EUA) fact sheets for the Janssen/Johnson & Johnson (J&J) COVID-19 vaccine to include information regarding an observed increased risk of Guillain-Barre Syndrome (GBS) after administration of the vaccine. […]
Dear COVID-19 Vaccination Program Provider: This message is being sent to all COVID-19 Vaccination Program enrolled providers in an effort to increase vaccinated individuals’ ability to obtain an Excelsior Pass. If you have not yet administered COVID-19 vaccine, you may disregard this message. Excelsior Pass mobile application is New York State’s voluntary and secure way […]
